These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10344611)

  • 1. Stability and compatibility of topotecan hydrochloride with selected drugs.
    Mayron D; Gennaro AR
    Am J Health Syst Pharm; 1999 May; 56(9):875-81. PubMed ID: 10344611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability and compatibility of granisetron hydrochloride in i.v. solutions and oral liquids and during simulated Y-site injection with selected drugs.
    Mayron D; Gennaro AR
    Am J Health Syst Pharm; 1996 Feb; 53(3):294-304. PubMed ID: 8808027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and chemical stability of gemcitabine hydrochloride solutions.
    Xu Q; Zhang Y; Trissel LA
    J Am Pharm Assoc (Wash); 1999; 39(4):509-13. PubMed ID: 10467815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers.
    Craig SB; Bhatt UH; Patel K
    J Pharm Biomed Anal; 1997 Oct; 16(2):199-205. PubMed ID: 9408834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration.
    Housman ST; Tessier PR; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2011 Dec; 68(23):2265-70. PubMed ID: 22095816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial inhibitory properties and stability of topotecan hydrochloride injection.
    Patel K; Craig SB; McBride MG; Palepu NR
    Am J Health Syst Pharm; 1998 Aug; 55(15):1584-7. PubMed ID: 9706184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of aztreonam with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1995 May; 52(10):1086-90. PubMed ID: 7656099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF; Simmons M
    J Am Pharm Assoc (Wash); 1999; 39(2):141-5. PubMed ID: 10079649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
    Woloschuk DM; Wermeling JR; Pruemer JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2158-60. PubMed ID: 1781472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated y-site administration.
    Trissel LA; Xu QA
    Int J Pharm Compd; 2005; 9(3):238-41. PubMed ID: 23924983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection.
    Wu G; Powers D; Yeung S; Chen F
    Int J Pharm Compd; 2018; 22(1):76-85. PubMed ID: 29385388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injection.
    Thompson DF; Stiles ML; Allen LV; Tu YH
    Am J Hosp Pharm; 1988 Jan; 45(1):142-5. PubMed ID: 3348228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF; Kim MC
    Am J Health Syst Pharm; 1997 Oct; 54(19):2192-6. PubMed ID: 9331439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride.
    Wu G; Powers D; Yeung S; Chen F; Neelon K
    Int J Pharm Compd; 2018; 22(1):86-94. PubMed ID: 29385389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of amrinone and digoxin, procainamide hydrochloride, propranolol hydrochloride, sodium bicarbonate, potassium chloride, or verapamil hydrochloride in intravenous admixtures.
    Riley CM; Junkin P
    Am J Hosp Pharm; 1991 Jun; 48(6):1245-52. PubMed ID: 1650135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility and stability of aloxi (palonosetron hydrochloride) admixed with dexamethasone sodium phosphate.
    Trissel LA; Zhang Y
    Int J Pharm Compd; 2004; 8(5):398-403. PubMed ID: 23924770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers.
    Bougouin C; Thelcide C; Crespin-Maillard F; Maillard C; Kinowski JM; Favier M
    Am J Health Syst Pharm; 2005 Oct; 62(19):2001-5. PubMed ID: 16174836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of flumazenil with selected drugs in 5% dextrose injection.
    Olsen KM; Gurley BJ; Davis GA; Christensen R; Monaghan MS
    Am J Hosp Pharm; 1993 Sep; 50(9):1907-12. PubMed ID: 8135238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility and stability of dexamethasone sodium phosphate and ketamine hydrochloride subcutaneous infusions in polypropylene syringes.
    Watson DG; Lin M; Morton A; Cable CG; McArthur DA
    J Pain Symptom Manage; 2005 Jul; 30(1):80-6. PubMed ID: 16043011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.